NDRG1 protein overexpression in malignant thyroid neoplasms

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• N-myc downstream-regulated gene 1 (NDRG1) protein expression is induced by various stimuli and implicated in diverse tumors.
• The specific role of NDRG1 in thyroid lesions has not been fully elucidated.
• Understanding NDRG1's function in thyroid pathology is crucial for potential diagnostic or prognostic applications.

Purpose of the Study:

• To investigate the expression patterns of NDRG1 protein in various benign and malignant thyroid lesions.
• To determine the correlation between NDRG1 expression and clinicopathological features of thyroid carcinomas.

Main Methods:

• Immunohistochemistry was employed to analyze NDRG1 protein expression.
• A tissue microarray containing 265 thyroid tissue fragments was utilized, including normal thyroid, goiter, adenoma, papillary carcinoma, follicular carcinoma, and metastases.
• A polyclonal anti-NDRG1 antibody was used for detection.

Main Results:

• NDRG1 expression was significantly higher in thyroid carcinomas than in normal thyroid glands and benign nodular goiters.
• Elevated NDRG1 levels were observed in classical papillary thyroid carcinomas and metastases (P < 0.001).
• Combined analysis revealed higher NDRG1 expression in malignant lesions compared to benign ones (P = 0.043), correlating with advanced TNM stage and high-risk AMES group.

Conclusions:

• Thyroid carcinomas exhibit increased NDRG1 protein expression compared to normal and benign thyroid tissues.
• NDRG1 expression levels are associated with more advanced tumor stages in thyroid cancer.
• These findings suggest NDRG1 may serve as a potential biomarker in thyroid carcinoma.